Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 8, Issue 1, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-12-05
DOI
10.1093/ofid/ofaa588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Roles of CD38 in the Immune Response to Infection
- (2020) Estibaliz Glaría et al. Cells
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- The Science Underlying COVID-19: Implications for the Cardiovascular System
- (2020) Peter P. Liu et al. CIRCULATION
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
- (2020) Abhigyan Choudhury et al. JOURNAL OF MEDICAL VIROLOGY
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- SARS-CoV-2 and viral sepsis: observations and hypotheses
- (2020) Hui Li et al. LANCET
- Therapeutic strategies for critically ill patients with COVID-19
- (2020) Lei Li et al. Annals of Intensive Care
- Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
- (2020) Wen Wen et al. Cell Discovery
- Dysregulated adaptive immune response contributes to severe COVID-19
- (2020) Kuai Yu et al. CELL RESEARCH
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Off-label therapy targeting pathogenic inflammation in COVID-19
- (2020) Luigina Romani et al. Cell Death Discovery
- COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential
- (2020) Yujie Jiang et al. CLINICAL IMMUNOLOGY
- Role of Leukotriene B4 Receptor-2 in Mast Cells in Allergic Airway Inflammation
- (2019) Sun-Young Kwon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Children With Autism Spectrum Disorder and Their Mothers Share Abnormal Expression of Selected Endogenous Retroviruses Families and Cytokines
- (2019) Emanuela Balestrieri et al. Frontiers in Immunology
- Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases
- (2018) Claudia Matteucci et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Thymosin alpha 1 and HIV-1: recent advances and future perspectives
- (2017) Claudia Matteucci et al. Future Microbiology
- Direct recognition of LPS drive TLR4 expressing CD8+ T cell activation in patients with rheumatoid arthritis
- (2017) Archana Tripathy et al. Scientific Reports
- Historical review on thymosin α1 in oncology: preclinical and clinical experiences
- (2015) Enrico Garaci et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Thymosin α 1 potentiates the release by CD8+cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infectionin vitro
- (2015) Claudia Matteucci et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Historical review of thymosin α 1 in infectious diseases
- (2015) Roberto Camerini et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-SARS coronavirus agents: a patent review (2008 – present)
- (2013) Vathan Kumar et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model
- (2013) Anne-Gaëlle Besnard et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-Like Receptors in Antiviral Innate Immunity
- (2013) Sandra N. Lester et al. JOURNAL OF MOLECULAR BIOLOGY
- Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1
- (2010) Claudia Matteucci et al. Annals of the New York Academy of Sciences
- The transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis
- (2008) Benno Weigmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now